Imaging Technology

AUGUST 29, 2023

Administration of the therapeutic dose took place as part of an ongoing Phase I/IIa theranostic clinical trial conducted by Clarity Pharmaceuticals to investigate the safety and efficacy of Cu-67 SARTATE in pediatric patients with high-risk neuroblastoma.

Pharmaceutical 97

Pharmaceutical Radiopharmaceuticals Clinic Medical 97

AuntMinnie

OCTOBER 30, 2024

GE HealthCare (GEHC) reported a 1% growth in existing operation revenues and an increase in profitability in its second quarter of 2024, citing solid performance in its Pharmaceutical Diagnostics segment. On an individual segment basis, GE HealthCare's Imaging segment had flat revenues year over year of $2.22

Healthcare 130

Healthcare Healthcare Pharmaceutical Ultrasound 130

Imaging Technology

MAY 25, 2023

is the only FDA approved FES PET imaging agent. Currently, when treating metastatic breast cancer patients, oncologists base clinical decisions on diagnostic tools including biopsy results which only represent the sampled area of the tumor. GE HealthCare’s Cerianna , available in the U.S.,

Clinic 94

Clinic Healthcare Healthcare Imaging 94

AuntMinnie

JANUARY 24, 2024

Enigma Biomedical Group USA (EBG-USA) has signed an exclusive agreement to commercialize AbbVie’s tau PET imaging biomarkers for use in patients with suspected neurodegenerative disease. Tau ligands labeled with F-18 radioisotopes are used as radiotracers during PET imaging to visualize this pathology.

Pharmaceutical 147

Pharmaceutical Disease Clinic Imaging 147

AuntMinnie

AUGUST 22, 2024

Food and Drug Administration (FDA) has granted Clarity Pharmaceuticals fast-track designation for its copper-64 (Cu-64) sarcophagine (SAR) bisPSMA radiopharmaceutical.

Pharmaceutical 130

Pharmaceutical Radiopharmaceuticals Disease Clinic 130

AuntMinnie

OCTOBER 22, 2024

Telix Pharmaceuticals plans to spin off its wholly-owned subsidiary Rhine Pharma and structure it as an independent company. Rhine Pharma’s mission will be to expand global access to radiopharmaceuticals for cancer imaging and treatment using two generator-produced isotopes, technetium-99m (Tc-99m) and rhenium-188 (Re-188), the company said.

Pharmaceutical 130

Pharmaceutical Radiopharmaceuticals Hospital Clinic 130

AuntMinnie

JUNE 3, 2024

Not long after the first United Theranostics center emerged from Advanced Molecular Imaging and Therapy, just prior to the pandemic era in Glen Burnie, MD, the practice is quickly evolving into a more concerted effort to design theranostics centers from the East Coast to the Southeast and Southwest, and subsequently throughout the U.S.,

Nuclear Medicine 264

Nuclear Medicine Radiopharmaceuticals Radiation Radiation Oncology 264

AuntMinnie

JANUARY 30, 2024

For many, machine learning's potential is more than just talk; the power of well-trained, image-augmented AI has already been demonstrated as a useful tool for quality control, disease tracking, tumor segmentation, and making prognosis predictions.

Medical Imaging 154

Medical Imaging Medical Radiology Imaging 154

AuntMinnie

JULY 12, 2024

As nuclear medicine therapies gain stature compared to nuclear medicine in diagnostic imaging, hospital administrators may be eyeing the potential of adding theranostics services. Beyder led a theranostics practice management and logistics track at the recent Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting in Toronto.

Nuclear Medicine 264

Nuclear Medicine Radiation Oncology Radiopharmaceuticals Radiation 264

AuntMinnie

JANUARY 15, 2024

and Project Data Sphere, a nonprofit initiative of the CEO Roundtable on Cancer, are partnering to improve tumor assessments using AI-enabled tools for clinical trials and cancer care. Food and Drug Administration (FDA), includes stakeholders and experts from across the pharmaceutical industry and academia.

Pharmaceutical 130

Pharmaceutical Medical Imaging Radiologist Clinic 130

AuntMinnie

OCTOBER 25, 2023

Clarity Pharmaceuticals, a clinical-stage radiopharmaceutical company, and PSI CRO, a global contract research organization, plan to conduct a trial using Clarity's phase III diagnostic trial of Clarify for prostate cancer patients. Clarity said the trial is expected to begin recruitment in late 2023.

Pharmaceutical 130

Pharmaceutical Radiopharmaceuticals Diagnostic Clinic 130

Imaging Technology

JULY 24, 2024

mtaschetta-millane Wed, 07/24/2024 - 11:17 July 24, 2024 — Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) has accepted the filing of its New Drug Application (NDA) for TLX007-CDx, a new and proprietary cold kit ("Kit") for the preparation of PSMA-PET imaging[1] for prostate cancer.

Imaging 105

Imaging Bone Scan Pharmaceutical Healthcare 105

Imaging Technology

JUNE 21, 2024

milla1cf Fri, 06/21/2024 - 20:24 June 21, 2024 — GE HealthCare , a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, and MediView XR Inc., Disclaimer: OmnifyXR is intended to be used adjunctively to standard of care imaging. 2] Paid consultant: Dr.

Interventional Radiology 105

Interventional Radiology Clinic Healthcare Healthcare 105

AuntMinnie

APRIL 22, 2024

"By not separating radiologist assistant reimbursement policies into different payment categories by service location, the adoption of MARCA would enable radiologists to devote more focused time to reviewing and interpreting complex medical images or urgent cases," the ASRT has said.

Radiology Technologist 264

Radiology Technologist Medicare Radiologist Basic Life Support 264

Imaging Technology

NOVEMBER 26, 2023

TeleDaaS specializes in delivering clinical-grade, precision-based dosimetry analysis and treatment plans to clinical research organizations (CROs) and pharmaceutical manufacturers. The life expectancy of patients on the personalized dosimetry arm of the trial increased to 26.6 months from 10.7

Clinic 78

Clinic Radiopharmaceuticals Radiosensitivity Pharmaceutical 78

AuntMinnie

DECEMBER 1, 2023

The scanner also comes with True Enhance DL, an AI-based application that generates deep learning-based monochromatic-like images from a single-energy x-ray acquisition. GEHC also pointed to upgrades for its Revolution Apex scanner, including ECG-less Cardiac for acquiring cardiac images without the need for an ECG signal or trace.

Healthcare 246

Healthcare Healthcare X-ray Ultrasound 246

Open Medscience

OCTOBER 1, 2024

ICH Q10 is a global model for managing pharmaceutical quality, ensuring compliance, continuous improvement, and risk manage The post The International Council for Harmonization (ICH) Q10: A Model for a Robust Pharmaceutical Quality Management System appeared first on Open MedScience.

Pharmaceutical 52

Pharmaceutical Quality and Compliance Risk Management Radiopharmaceuticals 52

AuntMinnie

JULY 29, 2024

Food and Drug Administration (FDA) has opened an expanded access program for Telix Pharmaceuticals' PET radiotracer TLX101-CDx (Pixclara, F-18 floretyrosine) for imaging progressive or recurring gliomas. Telix plans to file a new drug application with the FDA for radiotracer in the third quarter of this year, it said.

Pharmaceutical 100

Pharmaceutical Clinic IT Imaging 100

AuntMinnie

DECEMBER 4, 2023

The Evanston, IL-based company specializes in delivering dosimetry analysis and treatment plans to clinical research organizations and pharmaceutical manufacturers. The company offers scalable dosimetry services that integrate with existing imaging workflows in hospitals and cancer treatment research facilities.

Pharmaceutical 100

Pharmaceutical Radiation Hospital Clinic 100

AuntMinnie

JULY 18, 2024

AI imaging firm Brainomix has entered into a partnership with German pharmaceutical company Boehringer Ingelheim to improve the care of U.S. patients with fibrosing lung disease. Through the partnership, Brainomix will deploy its e-Lung software, which has 510(k) clearance from the U.S. Food and Drug Administration (FDA), to U.S.

Disease 100

Disease Pharmaceutical Clinic Imaging 100

Imaging Technology

JUNE 15, 2023

The clinical trial will use this investigational radiopharmaceutical to help understand if patients have CD8+ T cells in their tumors and will, therefore, be more likely to respond to immune checkpoint inhibitors, the main class of immunotherapies currently approved for use.

Radiopharmaceuticals 98

Radiopharmaceuticals Pharmaceutical Nuclear Medicine PET Scan 98

AuntMinnie

JUNE 10, 2024

Evans, PhD, has been named the 2024 recipient of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Sam Gambhir Trailblazer Award. He completed a postdoctoral fellowship in molecular imaging at Memorial Sloan Kettering Cancer Center. He will be honored at the SNMMI's annual meeting in Toronto.

Nuclear Medicine 100

Nuclear Medicine Radiopharmaceuticals Pharmaceutical Clinic 100

Imaging Technology

OCTOBER 11, 2023

Based on this agreement, GE HealthCare will take on global rights for [68Ga]FAPI-46 and outside-US rights for [18F]FAPI-74, originally developed at Heidelberg University in Germany, and both currently in Phase II clinical trials in the U.S. 68Ga]FAPI-46 (NCT05262855)2 and [18F]FAPI-74 (NCT05641896)3).

Healthcare 105

Healthcare Healthcare Pharmaceutical Radiopharmaceuticals 105

AuntMinnie

MAY 17, 2024

Imaging and radiology centers are among the least affected hospital services in Ukraine since the beginning of the Russian invasion in 2022, a study published May 17 in JAMA Health Forum found. The researchers reported that imaging and radiology centers were among the least affected services since the start of the war.

Radiology 182

Radiology Hospital Communication Pharmaceutical 182

Imaging Technology

JULY 25, 2024

Medical isotopes are essential for a wide range of diagnostic and therapeutic procedures, including cancer treatments and advanced imaging techniques. An active DMF enables clinical investigators or pharmaceutical companies to reference the filing in their regulatory submissions. a subsidiary of BWX Technologies, Inc.

Medical 105

Medical Radiopharmaceuticals Pharmaceutical Clinic 105

Imaging Technology

FEBRUARY 14, 2024

In 2024, PanTera will continue to work on increasing access to 225Ac for clinical trial needs, as well as on the development of a large-scale, state-of-the-art production facility to address growing global demand.

Pharmaceutical 105

Pharmaceutical Radiopharmaceuticals Medical Clinic 105

Imaging Technology

JULY 25, 2023

The ubiquitous expression of FAP in cancer-associated fibroblasts across nearly all epithelial-derived cancers paired with the low abundance in normal tissues, makes it a unique target to exploit for tumor imaging for a wide variety of cancers such as breast, pancreatic, lung and stomach cancer.

Radiopharmaceuticals 98

Radiopharmaceuticals Imaging Pharmaceutical Disease 98

Imaging Technology

JANUARY 21, 2025

The scientists will then use artificial intelligence and machine learning to analyze the image data, linked to relevant patient data on demographics, treatment history and pre-existing conditions. tim.hodson Tue, 01/21/2025 - 13:17 Jan. The blood vessels and neural pathways of retina and brain are intimately related.

Pharmaceutical 59

Pharmaceutical Public Health Disease Diagnose 59

Imaging Technology

MAY 5, 2023

milla1cf Fri, 05/05/2023 - 17:31 May 5, 2023 — The American College of Radiology ( ACR ), Breast Cancer Research Foundation (BCRF) and GE HealthCare announce the enrollment of the first patients in the Contrast-Enhanced Mammography Imaging Screening Trial (CMIST).

Healthcare 98

Healthcare Healthcare Imaging X-ray 98

Imaging Technology

JULY 25, 2024

a clinical-stage biotech developing groundbreaking secretome therapeutics for age and disease-related immune dysfunction, has announced a partnership with Springbok Analytics , a life sciences muscle analytics company. christine.book Thu, 07/25/2024 - 12:44 July 25, 2024 — Immunis, Inc. ,

MRI 104

MRI Pharmaceutical Disease Clinic 104

Imaging Technology

JULY 9, 2024

Marco Campione brings more than 25 years of experience from GE HealthCare, where he most recently served as Executive Director and Global Head of Contrast Media, General Manager Pharmaceutical Diagnostics North America and President GE HealthCare Inc., Blue Earth Diagnostics, an indirect subsidiary of Bracco Imaging S.p.A.,

Diagnostic 105

Diagnostic Radiopharmaceuticals Nuclear Medicine Magnetic Resonance Imaging 105

Imaging Technology

JULY 24, 2024

The company reports that the major update delivers the industry’s first multi-AI workflows, which simultaneously display results from more than one application in Proscia’s precision medicine AI portfolio on the same image. More information: www.proscia.com Wednesday, July 24, 2024 - 09:25

DICOM 115

DICOM Pharmaceutical Diagnostic Disease 115

Imaging Technology

FEBRUARY 12, 2024

The digital pathology solution was cleared for the purpose of primary diagnosis, reported the company, adding that it is cleared (K230839) for clinical use with the Hamamatsu NanoZoomer S360MD Slide scanner in the United States. Up to 70% of clinical decisions depend on pathology 1. Reference: 1. NHS England (2017).

Pharmaceutical 105

Pharmaceutical Clinic Diagnostic IT 105

Imaging Technology

JULY 11, 2023

The ubiquitous expression of FAP in cancer-associated fibroblasts across nearly all epithelial-derived cancers paired with the low abundance in normal tissues, makes it a unique target to exploit for tumor imaging for a wide variety of cancers such as breast, pancreatic, lung and stomach cancer.

Radiopharmaceuticals 75

Radiopharmaceuticals Imaging Pharmaceutical Disease 75

Imaging Technology

JULY 25, 2023

i] In a July 19 statement announcing the published research, Bracco Imaging added that it has launched gadopiclenol as VUEWAY (gadopiclenol) solution for injection and VUEWAY (gadopiclenol) Pharmacy Bulk Package, following the 2022 approval of gadopiclenol by the United States Food and Drug Administration (U.S. [i]

MRI 98

MRI Magnetic Resonance Imaging Imaging Diagnostic 98

AuntMinnie

OCTOBER 11, 2024

The agents affected include some of the most widely used contrast products in medical imaging. The recommendation was issued by the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA), the primary body in the European Union responsible for regulating pharmaceuticals.

MRI 147

MRI Radiologist Diagnostic Pharmaceutical 147

Imaging Technology

NOVEMBER 20, 2023

a pioneer in AI -driven predictive analytics using multi-modal data including text, signal, and image (US Patent No.11263749) a pioneer in AI -driven predictive analytics using multi-modal data including text, signal, and image (US Patent No.11263749) NeuroShield is currently in clinical use in over 220+ sites across the world.

Pharmaceutical 104

Pharmaceutical Healthcare Healthcare Medical Device 104